• BMP4-GPX4 Protects RGCs in NMDA Glaucoma Models

  2026-09-01

  The reference study identifies a BMP4–GPX4 axis that links retinal ganglion cell ferroptosis with the differentiation performance of transplanted retinal stem cells in an NMDA-based mouse glaucoma model. Its value lies in combining molecular evidence of oxidative and iron stress with a regenerative transplantation framework, while also highlighting important limits in model transferability.

• EMD638683: A Practical SGK1 Inhibitor Workflow

  2026-09-01

  EMD638683 enables mechanistic SGK1 studies that connect sodium-channel signaling, actin remodeling, endothelial stiffness, and downstream NDRG1 phosphorylation. This workflow translates vascular findings into controlled cell-based assays while outlining cautious extensions for cancer, hypertension, and proliferation research.

• Ranolazine: Metabolism, Ischemia, and Translation

  2026-08-31

  Ranolazine offers translational researchers a mechanistically defined way to connect late sodium current, calcium handling, myocardial relaxation, and metabolic substrate use. This article places those cardiac and hepatic effects alongside evidence that HBsAg redirects TBK1 signaling toward incomplete autophagy, while clearly distinguishing established findings from exploratory cross-domain hypotheses.

• Caspase-3 Fluorometric Assay Kit Workflow

  2026-08-31

  Turn apoptosis hypotheses into quantitative DEVD-dependent caspase activity data with a rapid, plate-based workflow. The K2007 assay is especially useful for connecting viability, mitochondrial stress, and autophagy findings in oncology models while providing practical controls for specificity and reproducibility.

• Spatial Sampling of Disease in Ambrosia Beetle Colonies

  2026-08-30

  This open-access STAR Protocols article presents an integrated workflow for rearing Xyleborus affinis, experimentally infecting colonies with Metarhizium, and tracking vertical, horizontal, and spatial pathogen transmission. Its main contribution is methodological: it combines colony manipulation, culture-based spatial sampling, CFU quantification, fluorescence imaging, and cryo-sectioning to make disease dynamics in social beetles experimentally accessible.

• Brain-Spinal Control of Opioid Mechanical Hypersensitivity

  2026-08-29

  Yin et al. identified a lateral parabrachial nucleus-to-spinal pathway involving MOR-positive, dynorphin-positive, and KOR-expressing GABAergic neurons that regulates morphine-induced mechanical hypersensitivity and analgesic tolerance in mice. The work separates mechanical opioid side effects from better-characterized thermal responses and provides a circuit-level framework for testing receptor and pathway contributions.

• 4-Hydroxytamoxifen: Practical Protocol & QC Guide

  2026-08-28

  4-Hydroxytamoxifen (SKU B6167) provides a DMSO-compatible estrogen receptor modulator for controlled in vitro studies and selected in vivo research workflows. It is appropriate for breast cancer research, prostate cancer research, apoptosis assay development, and cardiac myocyte calcium handling studies, but it should not be selected for protocols that require water- or ethanol-based solubilization without separate formulation validation.

• Cefazedone: From MIC Data to PK/PD Decisions

  2026-08-28

  Cefazedone (Refosporen) is examined through a practical lens that connects PBP-mediated cell-wall inhibition, MIC assay design, β-lactamase interpretation, and exposure-driven pharmacology. This evidence-focused guide distinguishes historical comparator data from product-specific findings to support more rigorous antibacterial research.

• Isoproterenol Sulfate Dihydrate in Pacemaker Assays

  2026-08-27

  Use Isoproterenol sulfate dihydrate to separate acute beta-adrenergic stimulation from slower, innervation-associated maturation in human pacemaker models. This workflow translates SAN-plexus assembloid biology into controlled cAMP/PKA, electrophysiology, and conduction assays with practical formulation and troubleshooting guidance.

• RSL3, PARP1, and Ferroptosis–Apoptosis Crosstalk

  2026-08-27

  The 2025 study identifies two coordinated routes by which RSL3 connects ferroptosis with apoptosis: caspase-dependent PARP1 cleavage and depletion of full-length PARP1 through impaired METTL3-mediated m6A regulation. Its cell, molecular, and xenograft experiments suggest that this mechanism may remain active in PARP inhibitor-resistant tumors, while also defining useful readouts for apoptosis research.

• Staurosporine: Mapping Heterogeneous Cell Killing

  2026-08-26

  Staurosporine is a broad-spectrum serine/threonine protein kinase inhibitor widely used to probe apoptosis and kinase signaling. This guide shows how time-resolved microscopy can distinguish population-level fractional killing from simple endpoint viability.

• CP-673451: A PDGFRα/β Assay Framework

  2026-08-26

  CP-673451 is a selective PDGFRα/β inhibitor with a strong biochemical-to-cellular evidence profile for cancer research. This article presents a decision framework linking target engagement, angiogenesis inhibition assay design, ATRX-aware glioma studies, and tumor growth suppression in xenograft models.

• Dehydroabietic Acid in PPAR Metabolic Workflows

  2026-08-25

  Build reproducible assays around Dehydroabietic acid, a dual PPAR-α/γ agonist for probing lipid metabolism regulation and insulin sensitivity. This workflow also shows how to connect PPAR experiments with the WTAP–GLS metabolic circuitry reported in hepatocellular carcinoma without overstating translational evidence.

• EMD638683: Practical SGK1 Inhibitor Workflows

  2026-08-25

  EMD638683 is a research-ready SGK1 inhibitor for linking kinase signaling with endothelial stiffness, sodium sensitivity, actin remodeling, and tumor-cell responses. This workflow-focused guide covers formulation, phospho-NDRG1 validation, phenotypic assays, and troubleshooting across vascular and cancer models.

• (+)-Bicuculline: Practical GABAA Workflow

  2026-08-24

  This guide provides a practical workflow for using (+)-Bicuculline as a GABAA receptor antagonist in studies of inhibitory synaptic transmission and neuronal signaling. It covers solvent selection, storage, preparation, controls, and interpretation boundaries; the compound is for controlled research use only and should not be used for diagnostic, clinical, or therapeutic purposes.

8017 records 1/535 page Next 12345 下5页 Last page